Karita Peltonen

10PUBLICATIONS
67CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 14, 2026
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

|Feb 04, 2026
Functionally Characterizing the Renal Cell Carcinoma Tumor-Immune Microenvironment via Patient-Derived Ex Vivo Models.

Neja Sirc, Johannes Smolander, Anita N Kumari

|Aug 23, 2025
Predicting antigen-specific T-cell immunity against Wilms tumor 1 in hematologic cancer.

Brittany L Ford, Emmi Jokinen, Jani Huuhtanen

|Oct 30, 2024
Ex vivo modeling of precision immuno-oncology responses in lung cancer.

Bassel Alsaed, Johannes Smolander, Hanna Laitinen

|Jul 24, 2023
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.

Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen

|Jul 24, 2021
Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy.

Karita Peltonen, Sara Feola, Husen M Umer

Pageof 2

Frequent Collaborators

6 joint publications

Satu Mustjoki

5 joint publications

Vincenzo Cerullo

4 joint publications

Sara Feola

4 joint publications

Leena Ylösmäki